May 21fibaqualifiers2022philippinesMoody's maintains WuXi AppTec Baa2fibaqualifiers2022philippinesThe issuer rating of the company has adjusted its outlook from stable to negative due to uncertainty caused by the proposed U.S. bill.
Moody's said the confirmation of WuXi AppTec's Baa2 issuer rating reflects the company's leading market position as a contract research institution with a full-service new drug research and development and manufacturing services platform in China, its low debt leverage and excellent liquidity.